MGLL and obesity disorder: We identified 15 studies that involved pharmacological or genetic manipulation of at least one of these enzymes and assessment of at least one obesity-related outcome in an animal model, and 30 studies that examined a genetic association between variants in the genes encoding FAAH and MAGL and obesity in humans.